Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_ANTIHYP
Extra metadata
List of similar endpoints to
Antihypertensive medication - note that there are other indications
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 134657 | 69693 | 64964 |
| Unadjusted prevalence (%) | 51.78 | 47.43 | 57.45 |
| Mean age at first event (years) | 54.28 | 53.15 | 55.48 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.02 | 1.88 [1.75, 2.02] | 3.6e-66 | 16327 |
| 15 years | 0.01 | 2.07 [1.93, 2.22] | 5.7e-96 | 11970 |
| 5 years | 0.00 | 2.10 [1.93, 2.29] | 6.0e-67 | 3156 |
| 1 year | 0.00 | 1.55 [1.31, 1.84] | 2.5e-7 | 453 |
Index endpoint: RX_ANTIHYP – Antihypertensive medication - note that there are other indications
GWS hits: 112
before Antihypertensive medication - note that there are other indications
after Antihypertensive medication - note that there are other indications
Loading survival analyses plot
Loading survival analyses table